Chinese english Germany Japanese Korea

6-(BETA-D-2-DEOXYRIBOFURANOSYL)-3,4-DIHYDRO-8H-PYRIMIDO-[4,5-C][1,2]OXAZIN-7-ONE

6-(BETA-D-2-DEOXYRIBOFURANOSYL)-3,4-DIHYDRO-8H-PYRIMIDO-[4,5-C][1,2]OXAZIN-7-ONE Struktur
126128-42-5
CAS-Nr.
126128-42-5
Englisch Name:
6-(BETA-D-2-DEOXYRIBOFURANOSYL)-3,4-DIHYDRO-8H-PYRIMIDO-[4,5-C][1,2]OXAZIN-7-ONE
Synonyma:
degenerate pyrimidine, protein mutagen;6-(β-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-one;6-(b-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-one;6-(β-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one;6-(β-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido [4,5-c][1,2]oxazin-7-one;6-(BETA-D-2-DEOXYRIBOFURANOSYL)-3,4-DIHYDRO-8H-PYRIMIDO-[4,5-C][1,2]OXAZIN-7-ONE;1H-Pyrimido[4,5-c][1,2]oxazin-7(3H)-one, 6-(2-deoxy-β-D-erythro-pentofuranosyl)-4,6-dihydro-;6-(2-Deoxy-beta-D-erythro-pentofuranosyl)-4,6-dihydro-1H-pyrimido(4,5-C)(1,2)oxazin-7(3H)-one
CBNumber:
CB0367039
Summenformel:
C11H15N3O5
Molgewicht:
269.25
MOL-Datei:
126128-42-5.mol
Request For Quotation

6-(BETA-D-2-DEOXYRIBOFURANOSYL)-3,4-DIHYDRO-8H-PYRIMIDO-[4,5-C][1,2]OXAZIN-7-ONE Eigenschaften

Sicherheit

6-(BETA-D-2-DEOXYRIBOFURANOSYL)-3,4-DIHYDRO-8H-PYRIMIDO-[4,5-C][1,2]OXAZIN-7-ONE Chemische Eigenschaften,Einsatz,Produktion Methoden

6-(BETA-D-2-DEOXYRIBOFURANOSYL)-3,4-DIHYDRO-8H-PYRIMIDO-[4,5-C][1,2]OXAZIN-7-ONE Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

6-(BETA-D-2-DEOXYRIBOFURANOSYL)-3,4-DIHYDRO-8H-PYRIMIDO-[4,5-C][1,2]OXAZIN-7-ONE Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 17)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Shenzhen Nexconn Pharmatechs Ltd 		+86-755-89396905 +86-15013857715
 admin@nexconn.com China 10248 58
BOC Sciences 		+1-631-485-4226
inquiry@bocsci.com United States 19553 58
NewCan Biotech Limited 		+86-0571-86912261 +8613735419629
 sales@newcanbio.com China 9976 58
PANNACEAN(HENAN)MEDICINE SCIENCE TECHNOLOGIES LTD 		0371-55159968 18137130222
 haifeng.zhang@pannacean.com China 409 58
Zhengzhou GranLen pharmaceutical Technology Co., Ltd. 0371-85513397
info@granlen.com China 497 55
Shenzhen Regent Biochemical Technology Co., Ltd. 0755-0755-85201366 18938635012
 sales@regentsciences.com China 9295 58
Zhengzhou Granlen Sciences, ltd. 0371-85513397
info@granlen.com China 1842 58
BOC Sciences 16314854226
 inquiry@bocsci.com United States 9713 58
Changzhou Furuisi Biotechnology Co., Ltd 0519-85524369
3477467573@qq.com China 8618 58
Wuhan Yingnuo Pharmaceutical Technology Co., Ltd. +86-027-59232304 15387063101
 2881924050@qq.com China 9892 58
  • 6-(BETA-D-2-DEOXYRIBOFURANOSYL)-3,4-DIHYDRO-8H-PYRIMIDO-[4,5-C][1,2]OXAZIN-7-ONE
  • 6-(2-Deoxy-beta-D-erythro-pentofuranosyl)-4,6-dihydro-1H-pyrimido(4,5-C)(1,2)oxazin-7(3H)-one
  • 6-(β-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-one
  • 6-(β-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one
  • 6-(b-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-one
  • 1H-Pyrimido[4,5-c][1,2]oxazin-7(3H)-one, 6-(2-deoxy-β-D-erythro-pentofuranosyl)-4,6-dihydro-
  • 6-(β-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido [4,5-c][1,2]oxazin-7-one
  • degenerate pyrimidine, protein mutagen
  • 126128-42-5
  • C11H15N3O5
Copyright 2019 © ChemicalBook. All rights reserved